Cpap Treatment Of Osahs With Dilated Cardiomyopathy Of Clinical Experience And Analysis

Objective To study patients of obstructive sleep apnea with complications of dilated cardiomyopathy and to observe the effect of continues positive airway pressure (CPAP) treatment. Method Clinical data of 4 obstructive sleep apnea hypopnea syndrome(OSAHS) patients were reviewed. Parameters including apnea hypopnea index (AHI), blood oxygen saturation (SpO2), left ventricular end diastolic diameter (LVEDD), fractional shortening (FS) and left ventricular ejection factor (LVEF) were measured and compared for 4 patients before and after the CPAP treatment. Results The data were gradually elevated [LVEF(49.00±1.82)%; LVEDD(62.00±10.73)mm;FS(22.48±2.71)%;AHI (10.25±4.42)/h;SpO2min(88.5±1.73)%; SpO2mean(91.251.50)%]compared with that [LVEF(38.25±4.11)%;LVEDD (73.75±11.14)mm; FS(20.62±5.13)%;AHI(62.20±16.73)/h;SpO2mi(68.25±11.84)%;SpO2mean (75.5±7.18)%] before the CPAP therapy。Conclusions Early diagnosis and treatment of OSAHS in patients with OSAHS and DCM has important clinical significance. Effective CPAP treatment may improve cardiac function and recover cardiac remodeling in patients with OSAHS and DCM.